The net proceeds from these warrant exercises, along with the net proceeds of approximately $141 million from the recent public offering that closed on February 20, 2026, and its existing cash and ...

As of Wednesday, February 25, United Therapeutics Corporation’s UTHR share price has surged by 10.84%, which has investors questioning if this is right time to sell.

After dumping its sole remaining gene therapy asset last year, Pfizer has decided to exercise its option for global rights to Beam Therapeutics’ liver-targeted gene editing candidate.

A growing body of preclinical research is converging on a provocative idea: that the mental health benefits of physical exercise might one day be delivered in pill form. Scientists have identified ...

Japan’s Chugai Pharmaceutical (TYO: 4519) and Swiss ADC specialist Araris Biotech have announced that the Tokyo firm has exercised its option under the research collaboration and option to license ...

KOSDAQ-listed LigaChem Biosciences is currently conducting clinical trials for LCB84, an antibody-drug conjugate (ADC) candidate. This was transferred to Janssen Biotech, a subsidiary of Johnson & ...

REHOVOT, Israel, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug ...

SEATTLE, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it ...

A substantial insider activity was disclosed on June 30, as Mason, Board Member at Krystal Biotech (NASDAQ:KRYS), reported the exercise of a large sell of company stock options. What Happened: In an ...

Kronos Bio is vacating its corporate headquarters amid a wider cost-cutting exercise for the struggling biotech. The company, which has been focused on developing small-molecule drugs for cancers and ...